| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |